학술논문
ER+, HER2− advanced breast cancer treated with taselisib and fulvestrant: genomic landscape and associated clinical outcomes
Document Type
Article
Author
Source
In: Molecular Oncology . (Molecular Oncology, October 2023, 17(10):2000-2016)
Subject
Language
English
ISSN
18780261
15747891
15747891